304 related articles for article (PubMed ID: 15916245)
1. Measurement of 3,4-MDMA and related amines in diagnostic and forensic laboratories.
Skrinska VA; Gock SB
Clin Lab Sci; 2005; 18(2):119-23. PubMed ID: 15916245
[TBL] [Abstract][Full Text] [Related]
2. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
[TBL] [Abstract][Full Text] [Related]
3. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of MDMA/MDA in both hair and urine in drug users.
Han E; Yang W; Lee J; Park Y; Kim E; Lim M; Chung H
Forensic Sci Int; 2005 Aug; 152(1):73-7. PubMed ID: 15939177
[TBL] [Abstract][Full Text] [Related]
5. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
6. The designer drug situation in Ibiza.
Lora-Tamayo C; Tena T; Rodríguez A; Moreno D; Sancho JR; Enseñat P; Muela F
Forensic Sci Int; 2004 Mar; 140(2-3):195-206. PubMed ID: 15036441
[TBL] [Abstract][Full Text] [Related]
7. [Ecstasy].
Trkulja V; Lacković Z
Lijec Vjesn; 1997; 119(5-6):158-66. PubMed ID: 9379824
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
Davis WM; Hatoum HT; Waters IW
Alcohol Drug Res; 1987; 7(3):123-34. PubMed ID: 2881551
[TBL] [Abstract][Full Text] [Related]
9. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
10. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair.
Wu YH; Lin KL; Chen SC; Chang YZ
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):192-202. PubMed ID: 18585989
[TBL] [Abstract][Full Text] [Related]
11. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)].
Verweij AM
Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250
[TBL] [Abstract][Full Text] [Related]
12. Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection.
Concheiro M; de Castro A; Quintela O; López-Rivadulla M; Cruz A
Forensic Sci Int; 2005 Jun; 150(2-3):221-6. PubMed ID: 15944063
[TBL] [Abstract][Full Text] [Related]
13. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
Nervenarzt; 1996 May; 67(5):369-80. PubMed ID: 9005345
[TBL] [Abstract][Full Text] [Related]
14. Fatality due to the use of a designer drug MDMA (Ecstasy).
Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E
Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
Maresová V; Chadt J; Prikryl L
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
[TBL] [Abstract][Full Text] [Related]
16. The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion.
Krotulski AJ; Mohr ALA; Fogarty MF; Logan BK
J Anal Toxicol; 2018 Oct; 42(8):544-553. PubMed ID: 30371847
[TBL] [Abstract][Full Text] [Related]
17. Distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in postmortem and antemortem specimens.
Liu RH; Liu HC; Lin DL
J Anal Toxicol; 2006 Oct; 30(8):545-50. PubMed ID: 17132249
[TBL] [Abstract][Full Text] [Related]
18. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
19. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
20. Hyperkalemia in fatal MDMA ('ecstasy') toxicity.
Raviña P; Quiroga JM; Raviña T
Int J Cardiol; 2004 Feb; 93(2-3):307-8. PubMed ID: 14975567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
